{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:10:50Z","timestamp":1684469450082},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1038\/ncpuro0212","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T14:30:52Z","timestamp":1119882652000},"page":"304-308","source":"Crossref","is-referenced-by-count":0,"title":["Locally advanced prostate cancer treated with radiotherapy and androgen deprivation"],"prefix":"10.1038","volume":"2","author":[{"given":"Roger","family":"Kirby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpuro0212_CR1","unstructured":"Aus G et al. (online 2004) European Association of Urology guidelines on prostate cancer. [\n                    http:\/\/www.uroweb.org\/files\/uploaded_files\/prostatecancer.pdf\n                    \n                  ] (accessed 18 May 2005)."},{"key":"BFncpuro0212_CR2","doi-asserted-by":"crossref","unstructured":"The Medical Research Council Prostate Cancer Working Party (1997) Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. Br J Urol 79: 235\u2013246","DOI":"10.1046\/j.1464-410X.1997.d01-6840.x"},{"key":"BFncpuro0212_CR3","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0022-5347(05)67032-2","volume":"164","author":"P Iversen","year":"2000","unstructured":"Iversen P et al. (2000) Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup. J Urol 164: 1579\u20131582","journal-title":"J Urol"},{"key":"BFncpuro0212_CR4","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1097\/01.ju.0000140159.94703.80","volume":"172","author":"MP Wirth","year":"2004","unstructured":"Wirth MP et al. (2004) Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years. J Urol 172 (Pt 1): 1865\u20131870","journal-title":"J Urol"},{"key":"BFncpuro0212_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0360-3016(01)01478-X","volume":"50","author":"PJ Chuba","year":"2001","unstructured":"Chuba PJ et al. (2001) The 1989 patterns of care study for prostate cancer: five-year outcomes. Int J Radiat Oncol Biol Phys 50: 325\u2013334","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFncpuro0212_CR6","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1002\/cncr.10919","volume":"95","author":"FA Vicini","year":"2002","unstructured":"Vicini FA et al. (2002) An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up. Cancer 95: 2126\u20132135","journal-title":"Cancer"},{"key":"BFncpuro0212_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0360-3016(00)00578-2","volume":"47","author":"M Roach","year":"2000","unstructured":"Roach M et al. (2000) Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials. Int J Radiat Oncol Biol Phys 47: 609\u2013615","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFncpuro0212_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0360-3016(00)00620-9","volume":"48","author":"A Pollack","year":"2000","unstructured":"Pollack A et al. (2000) External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys 48: 507\u2013512","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFncpuro0212_CR9","first-page":"152","volume":"5","author":"GE Hanks","year":"1999","unstructured":"Hanks GE et al. (1999) Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am 5: 152\u2013158","journal-title":"Cancer J Sci Am"},{"key":"BFncpuro0212_CR10","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0360-3016(01)01579-6","volume":"50","author":"MV Pilepich","year":"2001","unstructured":"Pilepich MV et al. (2001) Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys 50: 1243\u20131252","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFncpuro0212_CR11","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/01.ju.0000112979.97941.7f","volume":"171","author":"J Laverdi\u00e8re","year":"2004","unstructured":"Laverdi\u00e8re J et al. (2004) The efficacy and sequencing of a short course of androgen suppression on freedom from biochemical failure when administered with radiation therapy for T2-T3 prostate cancer. J Urol 171: 1137\u20131140","journal-title":"J Urol"},{"key":"BFncpuro0212_CR12","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1200\/JCO.2003.11.023","volume":"21","author":"GE Hanks","year":"2003","unstructured":"Hanks GE et al. (2003) Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol 21: 3972\u20133978","journal-title":"J Clin Oncol"},{"key":"BFncpuro0212_CR13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.ijrobp.2004.08.047","volume":"61","author":"MV Pilepich","year":"2005","unstructured":"Pilepich MV et al. (2005) Androgen suppression adjuvant to definitive radiotherapy in carcinomas of the prostate\u2014long term results of phase III RTOG 85-31. Int J Radiat Oncol Biol Phys 61: 1285\u20131290","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFncpuro0212_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","volume":"360","author":"M Bolla","year":"2002","unstructured":"Bolla M et al. (2002) Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360: 103\u2013106","journal-title":"Lancet"},{"key":"BFncpuro0212_CR15","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1097\/01.ju.0000127738.94221.da","volume":"171","author":"PR Sieber","year":"2004","unstructured":"Sieber PR et al. (2004) Bicalutamide 150 mg maintains bone mineral density during monotherapy for localized or locally advanced prostate cancer. J Urol 171 (Pt 1): 2272\u20132276","journal-title":"J Urol"},{"key":"BFncpuro0212_CR16","first-page":"400","volume":"22","author":"F Boccardo","year":"2003","unstructured":"Boccardo F et al. (2003) Tamoxifen (T) is more effective than anastrozole (A) in preventing gynecomastia induced by bicalutamide (B) monotherapy in prostate cancer (pca) patients (pts) [abstract 1608]. Proc Am Soc Clin Oncol 22: 400","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BFncpuro0212_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ijrobp.2004.03.022","volume":"60","author":"CJ Tyrrell","year":"2004","unstructured":"Tyrrell CJ et al. (2004) Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. Int J Radiat Oncol Biol Phys 60: 476\u2013483","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Nature Clinical Practice Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0212","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpuro0212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:08:17Z","timestamp":1684440497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpuro0212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["BFncpuro0212"],"URL":"https:\/\/doi.org\/10.1038\/ncpuro0212","relation":{},"ISSN":["1743-4270","1743-4289"],"issn-type":[{"value":"1743-4270","type":"print"},{"value":"1743-4289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}